Objective: To identify clinical features of dementia with Lewy bodies (DLB) least likely
associated with Alzheimer's disease pathology, and to determine whether it is associated …

Abstract Introduction The National Institute on Aging Alzheimer's Disease Research Center
program added the Lewy body dementia module (LBD‐MOD) to the Uniform Data Set to …

BackgroundThe accurate clinical characterisation of mild cognitive impairment (MCI) is
becoming increasingly important. The aim of this study was to compare the neuropsychiatric …

Background Distinguishing between early Dementia with Lewy bodies (DLB) and
Alzheimer's disease (AD) is important to facilitate early treatment, to prevent iatrogenic …

Background Little is known about the clinical presentation and prognosis of patients with
mild cognitive impairment with Lewy Bodies (MCI‐LB). We aimed to describe clinical …

Quantitative EEG (QEEG) has demonstrated good discriminative capacity for dementia with
Lewy bodies (DLB) diagnosis as compared to Alzheimer's disease (AD) with a predictive …

Introduction: Previous studies on electroencephalography (EEG) to discriminate between
dementia with Lewy bodies (DLB) and Alzheimer's disease (AD) have been promising …

Limited information regarding the specificity of mild cognitive impairment (MCI) as it relates
to dementia with Lewy bodies (DLB) exists. Here, we summarize the clinical phenotype of …

Dementia with Lewy bodies (DLB) is strongly associated with Alzheimer disease (AD)-type
pathology and tends to mask the core clinical features of DLB. Therefore, there may be …

Background Isolated subjective cognitive impairment (SCI) and mild cognitive impairment
(MCI) are the prodromal phases of dementia with Lewy bodies (DLB). MEMENTO is a …